February 3, 2025 · Form 4 insider transaction
Hooftman Leon bought 140,000 shares of Barinthus Biotherapeutics plc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.